SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

LUNGHI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.589
EU - Europa 1.228
AS - Asia 740
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 6.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.578
CN - Cina 414
UA - Ucraina 315
IT - Italia 258
DE - Germania 202
TR - Turchia 161
GB - Regno Unito 142
SG - Singapore 99
SE - Svezia 75
PL - Polonia 68
FI - Finlandia 65
BE - Belgio 19
FR - Francia 19
NL - Olanda 19
HK - Hong Kong 16
CZ - Repubblica Ceca 15
ID - Indonesia 15
VN - Vietnam 12
CA - Canada 11
GR - Grecia 7
IR - Iran 7
IN - India 6
CH - Svizzera 5
JP - Giappone 4
RO - Romania 4
PT - Portogallo 3
TW - Taiwan 3
AL - Albania 2
ES - Italia 2
EU - Europa 2
IE - Irlanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
MK - Macedonia 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 6.563
Salva come PNG Salva come JPEG
Città #
Woodbridge 595
Fairfield 594
Houston 381
Chandler 369
Jacksonville 344
Ashburn 271
Seattle 252
Ann Arbor 239
Wilmington 210
Cambridge 194
New York 169
Izmir 102
Nanjing 97
Ferrara 95
Boardman 93
Princeton 84
Beijing 74
Warsaw 68
San Diego 57
Singapore 56
Milan 44
Dearborn 37
Shanghai 36
Shenyang 36
Bremen 31
Hebei 24
Munich 22
Jiaxing 20
Tianjin 20
Nanchang 19
Brussels 18
Redwood City 18
Changsha 16
Hong Kong 16
Jakarta 15
Brno 13
Mountain View 13
Auburn Hills 12
Des Moines 12
Kunming 12
Mcallen 12
Norwalk 12
Rome 12
Dong Ket 11
Düsseldorf 10
London 9
Redmond 9
Hangzhou 8
Jinan 8
Montréal 8
San Mateo 8
Abdullah 6
Chicago 6
Falls Church 5
Monmouth Junction 5
Orange 5
Verona 5
Zhengzhou 5
Bologna 4
Castelcovati 4
Florence 4
Fuzhou 4
Helsinki 4
Los Angeles 4
Ningbo 4
Padova 4
Sala 4
Shenzhen 4
Augusta 3
Hefei 3
Hyderabad 3
Lusia 3
Mülheim-kärlich 3
Reggio Nell'emilia 3
Tappahannock 3
Washington 3
Addison 2
Albignasego 2
Athens 2
Atlanta 2
Catania 2
Changchun 2
Dronten 2
Ferrara di Monte Baldo 2
Genoa 2
Genova 2
Guangzhou 2
Haikou 2
Hounslow 2
Islington 2
Jinhua 2
Madrid 2
Meppel 2
Milazzo 2
Olomouc 2
Paris 2
Pavia 2
Rimini 2
Swansea 2
Taizhou 2
Totale 5.034
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 179
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 157
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 154
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 143
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 142
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 141
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 137
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 130
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 128
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 127
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 116
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 115
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 113
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 110
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 109
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 108
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 104
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 103
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 102
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 101
An underestimated combination of opposites resulting in enhanced thrombotic tendency 100
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 99
The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels. 99
Venous thromboembolism in young women - Role of thrombophilic mutations and oral contraceptive use 98
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 96
Risks factors for highly unstable response to oral anticoagulation: a case-control study 96
null 95
Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro- progestins 95
Modulation of factor V levels in plasma by polymorphisms in the C2 domain 94
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? 93
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299 Arg substitutions in factor V 92
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 91
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 91
Resistance to activated protein C in healthy women taking oral contraceptives 91
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 91
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation. 90
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation. 90
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 90
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 90
null 88
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 86
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 84
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 82
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population. 81
Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis 78
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 77
Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma 77
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 76
Increased Susceptibility to Proteases in Type 2A von Willebrand Disease Associated with two Novel Mutations (Val 867 Glu, Pro 864 His). 74
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 73
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 73
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 70
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 69
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies 67
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 65
null 63
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 63
Polimorfismi funzionali e terapia anticoagulante 62
CMR+ Factor V deficiency Arg2080Cys: A model to investigate altered C2 domain-membrane interaction. 62
Functional genetics 59
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women 58
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 57
Studio di Mutazioni in Geni dell'Emostasi. 52
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 52
Expression and characterization of a factor V mutation (E1608K) detected in familial thrombophilia. 51
Evaluation of FV mRNA to define the residual FV expression levels in severe FV deficiency 50
Detection of New Polymorphic Markers in the Factor V Gene. 46
Lesioni molecolari ricorrenti sono responsabili di difetti funzionali del fattore VII. 45
Studio di mutazioni in geni dell’emostasi. 45
Hemostasis gene expression of the internal jugular and saphenous veins 43
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 41
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 41
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 37
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 35
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 35
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 29
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A 27
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 22
Combination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients 20
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 16
Factor V Kuwait alias factor V R3: A rare polymorphism of uncertain functional significance 13
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors 11
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 11
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 7
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 6
Genetic components in factor VIII receptors for individual and genotype-modeled hemophilia A treatment 5
ASSOCIATION OF MEMBRANOUS NEPHROPATHY WITH FAMILIAL RESISTANCE TO ACTIVATED PROTEIN-C 5
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited 3
Totale 6.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.474 215 40 51 208 98 182 152 159 118 154 58 39
2020/20211.119 110 101 76 118 38 100 91 116 41 138 134 56
2021/2022903 96 87 47 71 50 18 54 47 21 59 83 270
2022/2023902 93 78 24 109 130 130 67 76 100 15 46 34
2023/2024563 34 39 18 20 36 183 9 26 17 7 13 161
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 6.692